Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-12

AUTHORS

Qiyuan Chen, Heather Jackson, Peter Gibbs, Ian D. Davis, Joseph Trapani, Jonathan Cebon

ABSTRACT

The spontaneous cytotoxic T cell responses to melanoma differentiation antigens and influenza matrix peptide were compared in 20 HLA-A2+ melanoma patients and 17 healthy A2+ individuals. Cytotoxic T lymphocyte (CTL) responses were determined by mixed lymphocyte peptide culture (MLPC) involving two stimulations of unfractionated peripheral blood lymphocytes (PBLs) with peptide in vitro. CTL responses to Melan-A 9-mer (amino acids 27-35, AAGIGILTV) peptide were detected in 4 out of 16 normal individuals, but in none of the melanoma patients. CTL specific for influenza matrix peptide were frequently found in both normal individuals and melanoma patients, suggesting that generalized immuno-suppression was not responsible for this difference. No significant responses were observed in either normal individuals or melanoma patients to Melan-A 10-mer (26-35, EAAGIGILTV), two gp1OO epitopes (280-288, YLEPGPVTA; 457466, LLDGTATLRL) and two tyrosinase epitopes (1-9, MLLAVLYCL; 368-376, YMDGMSQV). Melan-A (27-35)-specific CTL cells generated by normal individuals and melanoma patients recognized both synthetic peptide-pulsed T2 cells and two HLA-A2+, Melan-A+ melanoma cell lines (ME272, LAR1) in an antigen-specific, MHC class I restricted manner. T cells generated against Melan-A 9-mer were also able to recognize Melan-A 10-mer-pulsed target cells. Spontaneous CTL responses to Melan-A 9-mer from three known responder normal individuals were further evaluated over a prolonged time course (6-11 months). All 3 subjects demonstrated specific Melan-A 9-mer responses throughout the study period, although lytic activity fluctuated over time for a given individual. We found the MLPC assay to be reliable and easy to perform for monitoring T cell responses, although it may still not be sufficiently sensitive to detect low numbers of precursor T cells. More... »

PAGES

191-197

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002620050520

DOI

http://dx.doi.org/10.1007/s002620050520

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000301184

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9875671


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adjuvants, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MART-1 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligopeptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Cytotoxic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Repat Cancer Centre, Heidelberg, VIC 3084, Australia, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Qiyuan", 
        "id": "sg:person.01033371456.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033371456.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Repat Cancer Centre, Heidelberg, VIC 3084, Australia, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jackson", 
        "givenName": "Heather", 
        "id": "sg:person.0656012437.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656012437.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Repat Cancer Centre, Heidelberg, VIC 3084, Australia, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gibbs", 
        "givenName": "Peter", 
        "id": "sg:person.01343063505.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343063505.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Repat Cancer Centre, Heidelberg, VIC 3084, Australia, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "Ian D.", 
        "id": "sg:person.015150221037.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015150221037.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin Hospital, Heidelberg, VIC 3084, Australia, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trapani", 
        "givenName": "Joseph", 
        "id": "sg:person.01264555113.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264555113.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Ludwig Institute for Cancer Research,  Oncology, Austin Hospital, Heidelberg, VIC 3084, Australia e-mail: Jonathan.Cebon@Ludwig.edu.au Tel.: +6-3-94576933,Fax: +6-3-94576698, AU"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cebon", 
        "givenName": "Jonathan", 
        "id": "sg:person.01104611322.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104611322.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ijc.2910630313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004438641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-199607000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007701776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-199607000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007701776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910510209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018000653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.180.1.347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023959186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910500220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028685037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-5699(97)80020-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028739884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.178.2.489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033051074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.94.5.1914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033090823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01525314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044784980", 
          "https://doi.org/10.1007/bf01525314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.14.6458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049481800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.184.2.647", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051923456"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-12", 
    "datePublishedReg": "1998-12-01", 
    "description": "The spontaneous cytotoxic T cell responses to melanoma differentiation antigens and influenza matrix peptide were compared in 20 HLA-A2+ melanoma patients and 17 healthy A2+ individuals. Cytotoxic T lymphocyte (CTL) responses were determined by mixed lymphocyte peptide culture (MLPC) involving two stimulations of unfractionated peripheral blood lymphocytes (PBLs) with peptide in vitro. CTL responses to Melan-A 9-mer (amino acids 27-35, AAGIGILTV) peptide were detected in 4 out of 16 normal individuals, but in none of the melanoma patients. CTL specific for influenza matrix peptide were frequently found in both normal individuals and melanoma patients, suggesting that generalized immuno-suppression was not responsible for this difference. No significant responses were observed in either normal individuals or melanoma patients to Melan-A 10-mer (26-35, EAAGIGILTV), two gp1OO epitopes (280-288, YLEPGPVTA; 457466, LLDGTATLRL) and two tyrosinase epitopes (1-9, MLLAVLYCL; 368-376, YMDGMSQV). Melan-A (27-35)-specific CTL cells generated by normal individuals and melanoma patients recognized both synthetic peptide-pulsed T2 cells and two HLA-A2+, Melan-A+ melanoma cell lines (ME272, LAR1) in an antigen-specific, MHC class I restricted manner. T cells generated against Melan-A 9-mer were also able to recognize Melan-A 10-mer-pulsed target cells. Spontaneous CTL responses to Melan-A 9-mer from three known responder normal individuals were further evaluated over a prolonged time course (6-11 months). All 3 subjects demonstrated specific Melan-A 9-mer responses throughout the study period, although lytic activity fluctuated over time for a given individual. We found the MLPC assay to be reliable and easy to perform for monitoring T cell responses, although it may still not be sufficiently sensitive to detect low numbers of precursor T cells.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002620050520", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects", 
    "pagination": "191-197", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "016e5e532060874ebf20602c849fe54608d0d49c565b18c1cc7bc9fd28b6fd6f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9875671"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8605732"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002620050520"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000301184"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002620050520", 
      "https://app.dimensions.ai/details/publication/pub.1000301184"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000529.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs002620050520"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002620050520'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002620050520'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002620050520'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002620050520'


 

This table displays all metadata directly associated to this object as RDF triples.

185 TRIPLES      21 PREDICATES      51 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002620050520 schema:about N06c961a689f04a0a8015ae763e77a47b
2 N28b25e4388004baba7881a12ef0df9ef
3 N73e58e1f978f48238080aa5d5123c6a2
4 N828de48e11d4441e8b875c874da9fbf4
5 N8a631b1476d64d5e86005555c38afa0b
6 N8f40592d004e4a02b9a304bba6a86c8e
7 N9b727318bee44db98cdf891e5bda200a
8 Nb44908c7417a41948be80a4892b07f83
9 Nc2680e4c3db44508995f18c44b64a547
10 Nc5d4dfc6e2af43e9933dcd4449d8a111
11 Nf8b8c17d6d294743999b914a3390f1e3
12 anzsrc-for:11
13 anzsrc-for:1107
14 schema:author N4f5b3f101a6649678759b119a64e76e4
15 schema:citation sg:pub.10.1007/bf01525314
16 https://doi.org/10.1002/ijc.2910500220
17 https://doi.org/10.1002/ijc.2910510209
18 https://doi.org/10.1002/ijc.2910630313
19 https://doi.org/10.1016/s0167-5699(97)80020-5
20 https://doi.org/10.1073/pnas.91.14.6458
21 https://doi.org/10.1073/pnas.94.5.1914
22 https://doi.org/10.1084/jem.178.2.489
23 https://doi.org/10.1084/jem.180.1.347
24 https://doi.org/10.1084/jem.184.2.647
25 https://doi.org/10.1097/00002371-199607000-00003
26 schema:datePublished 1998-12
27 schema:datePublishedReg 1998-12-01
28 schema:description The spontaneous cytotoxic T cell responses to melanoma differentiation antigens and influenza matrix peptide were compared in 20 HLA-A2+ melanoma patients and 17 healthy A2+ individuals. Cytotoxic T lymphocyte (CTL) responses were determined by mixed lymphocyte peptide culture (MLPC) involving two stimulations of unfractionated peripheral blood lymphocytes (PBLs) with peptide in vitro. CTL responses to Melan-A 9-mer (amino acids 27-35, AAGIGILTV) peptide were detected in 4 out of 16 normal individuals, but in none of the melanoma patients. CTL specific for influenza matrix peptide were frequently found in both normal individuals and melanoma patients, suggesting that generalized immuno-suppression was not responsible for this difference. No significant responses were observed in either normal individuals or melanoma patients to Melan-A 10-mer (26-35, EAAGIGILTV), two gp1OO epitopes (280-288, YLEPGPVTA; 457466, LLDGTATLRL) and two tyrosinase epitopes (1-9, MLLAVLYCL; 368-376, YMDGMSQV). Melan-A (27-35)-specific CTL cells generated by normal individuals and melanoma patients recognized both synthetic peptide-pulsed T2 cells and two HLA-A2+, Melan-A+ melanoma cell lines (ME272, LAR1) in an antigen-specific, MHC class I restricted manner. T cells generated against Melan-A 9-mer were also able to recognize Melan-A 10-mer-pulsed target cells. Spontaneous CTL responses to Melan-A 9-mer from three known responder normal individuals were further evaluated over a prolonged time course (6-11 months). All 3 subjects demonstrated specific Melan-A 9-mer responses throughout the study period, although lytic activity fluctuated over time for a given individual. We found the MLPC assay to be reliable and easy to perform for monitoring T cell responses, although it may still not be sufficiently sensitive to detect low numbers of precursor T cells.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf N4bdc8a934416425f8ad39499e4372ba7
33 Nd62324f8257740b884a3cb45c7716fd8
34 sg:journal.1096240
35 schema:name Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects
36 schema:pagination 191-197
37 schema:productId N45f6fa113f204e99b205d3e2d9e0700e
38 N49ff8b5f77224b6ea6349a6a6172c8f3
39 N89bcb5e178f540ba86f7ef51c9f03477
40 Nb9a457288296436db2b0715b625905f1
41 Ne350282e3c7d4791964246a5b8f48e42
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000301184
43 https://doi.org/10.1007/s002620050520
44 schema:sdDatePublished 2019-04-10T18:24
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher Ncd9b1e804aac42cebe74390f6eb4189b
47 schema:url http://link.springer.com/10.1007%2Fs002620050520
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N06c961a689f04a0a8015ae763e77a47b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Adjuvants, Immunologic
53 rdf:type schema:DefinedTerm
54 N28b25e4388004baba7881a12ef0df9ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name T-Lymphocytes, Cytotoxic
56 rdf:type schema:DefinedTerm
57 N45f6fa113f204e99b205d3e2d9e0700e schema:name readcube_id
58 schema:value 016e5e532060874ebf20602c849fe54608d0d49c565b18c1cc7bc9fd28b6fd6f
59 rdf:type schema:PropertyValue
60 N49ff8b5f77224b6ea6349a6a6172c8f3 schema:name nlm_unique_id
61 schema:value 8605732
62 rdf:type schema:PropertyValue
63 N4bdc8a934416425f8ad39499e4372ba7 schema:volumeNumber 47
64 rdf:type schema:PublicationVolume
65 N4f5b3f101a6649678759b119a64e76e4 rdf:first sg:person.01033371456.07
66 rdf:rest N84227876014644eab65d6dbccadde14d
67 N563b12f227f84261ae14c3dc872f0476 rdf:first sg:person.01104611322.03
68 rdf:rest rdf:nil
69 N6449e63964e941ecb504085ae43d41f4 rdf:first sg:person.015150221037.29
70 rdf:rest N720e0cd927864c1abd4bb7282284a85e
71 N7058e64a6bec44d19ee70f56a39f7b20 schema:name Cellular Cytotoxicity Laboratory, Austin Research Institute, Austin Hospital, Heidelberg, VIC 3084, Australia, AU
72 rdf:type schema:Organization
73 N720e0cd927864c1abd4bb7282284a85e rdf:first sg:person.01264555113.03
74 rdf:rest N563b12f227f84261ae14c3dc872f0476
75 N73e58e1f978f48238080aa5d5123c6a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Neoplasm Proteins
77 rdf:type schema:DefinedTerm
78 N828de48e11d4441e8b875c874da9fbf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Lymphocyte Activation
80 rdf:type schema:DefinedTerm
81 N84227876014644eab65d6dbccadde14d rdf:first sg:person.0656012437.38
82 rdf:rest Nb3fbb477fd78478a8d19b392a73e0acb
83 N89bcb5e178f540ba86f7ef51c9f03477 schema:name dimensions_id
84 schema:value pub.1000301184
85 rdf:type schema:PropertyValue
86 N8a631b1476d64d5e86005555c38afa0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Amino Acid Sequence
88 rdf:type schema:DefinedTerm
89 N8f40592d004e4a02b9a304bba6a86c8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Melanoma
91 rdf:type schema:DefinedTerm
92 N9b727318bee44db98cdf891e5bda200a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Humans
94 rdf:type schema:DefinedTerm
95 Nb3fbb477fd78478a8d19b392a73e0acb rdf:first sg:person.01343063505.31
96 rdf:rest N6449e63964e941ecb504085ae43d41f4
97 Nb44908c7417a41948be80a4892b07f83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Antigens, Differentiation
99 rdf:type schema:DefinedTerm
100 Nb9a457288296436db2b0715b625905f1 schema:name doi
101 schema:value 10.1007/s002620050520
102 rdf:type schema:PropertyValue
103 Nc2680e4c3db44508995f18c44b64a547 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name MART-1 Antigen
105 rdf:type schema:DefinedTerm
106 Nc5d4dfc6e2af43e9933dcd4449d8a111 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Oligopeptides
108 rdf:type schema:DefinedTerm
109 Ncd9b1e804aac42cebe74390f6eb4189b schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 Nd62324f8257740b884a3cb45c7716fd8 schema:issueNumber 4
112 rdf:type schema:PublicationIssue
113 Ne350282e3c7d4791964246a5b8f48e42 schema:name pubmed_id
114 schema:value 9875671
115 rdf:type schema:PropertyValue
116 Nf8b8c17d6d294743999b914a3390f1e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Antigens, Neoplasm
118 rdf:type schema:DefinedTerm
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
123 schema:name Immunology
124 rdf:type schema:DefinedTerm
125 sg:journal.1096240 schema:issn 0340-7004
126 1432-0851
127 schema:name Cancer Immunology, Immunotherapy
128 rdf:type schema:Periodical
129 sg:person.01033371456.07 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
130 schema:familyName Chen
131 schema:givenName Qiyuan
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033371456.07
133 rdf:type schema:Person
134 sg:person.01104611322.03 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
135 schema:familyName Cebon
136 schema:givenName Jonathan
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104611322.03
138 rdf:type schema:Person
139 sg:person.01264555113.03 schema:affiliation N7058e64a6bec44d19ee70f56a39f7b20
140 schema:familyName Trapani
141 schema:givenName Joseph
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264555113.03
143 rdf:type schema:Person
144 sg:person.01343063505.31 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
145 schema:familyName Gibbs
146 schema:givenName Peter
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343063505.31
148 rdf:type schema:Person
149 sg:person.015150221037.29 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
150 schema:familyName Davis
151 schema:givenName Ian D.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015150221037.29
153 rdf:type schema:Person
154 sg:person.0656012437.38 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
155 schema:familyName Jackson
156 schema:givenName Heather
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656012437.38
158 rdf:type schema:Person
159 sg:pub.10.1007/bf01525314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044784980
160 https://doi.org/10.1007/bf01525314
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1002/ijc.2910500220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028685037
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1002/ijc.2910510209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018000653
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1002/ijc.2910630313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004438641
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0167-5699(97)80020-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028739884
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1073/pnas.91.14.6458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049481800
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1073/pnas.94.5.1914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033090823
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1084/jem.178.2.489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033051074
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1084/jem.180.1.347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023959186
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1084/jem.184.2.647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051923456
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1097/00002371-199607000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007701776
181 rdf:type schema:CreativeWork
182 https://www.grid.ac/institutes/grid.482095.2 schema:alternateName Ludwig Institute for Cancer Research
183 schema:name Ludwig Institute for Cancer Research, Oncology, Austin Hospital, Heidelberg, VIC 3084, Australia e-mail: Jonathan.Cebon@Ludwig.edu.au Tel.: +6-3-94576933,Fax: +6-3-94576698, AU
184 Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Repat Cancer Centre, Heidelberg, VIC 3084, Australia, AU
185 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...